tiprankstipranks
Advertisement
Advertisement

RNXT Stock Latest News

RenovoRx Granted Extended Nasdaq Compliance Period Amid Listing Risk
Company AnnouncementsRenovoRx Granted Extended Nasdaq Compliance Period Amid Listing Risk
19d ago
8K
RNXT
RenovoRx Stockholders Approve Directors and Equity Plan
PremiumCompany Announcements
RenovoRx Stockholders Approve Directors and Equity Plan
21d ago
8K
RNXT
RenovoRx announces FDA Orphan Drug Designation for oxaliplatin
PremiumThe Fly
RenovoRx announces FDA Orphan Drug Designation for oxaliplatin
2M ago
RNXT
RenovoRx announces pharmacokinetic data using TAMP platform
PremiumThe Fly
RenovoRx announces pharmacokinetic data using TAMP platform
2M ago
RNXT
RenovoRx Earnings Call Signals Commercial Inflection
PremiumCompany Announcements
RenovoRx Earnings Call Signals Commercial Inflection
2M ago
RNXT
RenovoRx reports Q1 adjusted EPS (8c), consensus (8c)
PremiumThe FlyRenovoRx reports Q1 adjusted EPS (8c), consensus (8c)
2M ago
RNXT
RenovoRx sees FY26 revenue $3M-$4M, consensus $3.24M
Premium
The Fly
RenovoRx sees FY26 revenue $3M-$4M, consensus $3.24M
2M ago
RNXT
RenovoRx files to sell 8.44M shares of common stock for holders
Premium
The Fly
RenovoRx files to sell 8.44M shares of common stock for holders
3M ago
RNXT
RenovoRx: Building Commercial Momentum Ahead of TIGeR-PaC Readout Supports Buy-Rated Risk‑Reward Profile
PremiumRatings
RenovoRx: Building Commercial Momentum Ahead of TIGeR-PaC Readout Supports Buy-Rated Risk‑Reward Profile
3M ago
RNXT
RenovoRx secures Japanese patent allowance for targeted drug-delivery
PremiumThe Fly
RenovoRx secures Japanese patent allowance for targeted drug-delivery
3M ago
RNXT
RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial
PremiumCompany Announcements
RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial
4M ago
8K
RNXT
RNXT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RNXT Upcoming Earnings Report: What to Expect?
4M ago
RNXT
RenovoRx’s TIGeR-PaC Phase III trial surpasses 100 randomized patients
PremiumThe FlyRenovoRx’s TIGeR-PaC Phase III trial surpasses 100 randomized patients
4M ago
RNXT
RenovoRx Raises $10 Million in Oversubscribed Private Placement
Premium
Company Announcements
RenovoRx Raises $10 Million in Oversubscribed Private Placement
4M ago
8K
RNXT
RenovoRx prices 10.6M shares at 93.8c in private placement
Premium
The Fly
RenovoRx prices 10.6M shares at 93.8c in private placement
4M ago
RNXT
RenovoRx advances RenovoCath adoption at U.S. cancer centers
PremiumThe Fly
RenovoRx advances RenovoCath adoption at U.S. cancer centers
5M ago
RNXT
RenovoRx announces acceptance of clinical data abstract at 2026 SIR
PremiumThe Fly
RenovoRx announces acceptance of clinical data abstract at 2026 SIR
5M ago
RNXT
RenovoRx establishes RenovoCath Medical Advisory Board
PremiumThe Fly
RenovoRx establishes RenovoCath Medical Advisory Board
5M ago
RNXT
RenovoRx Appoints Veteran Executive Mark Voll as CFO
PremiumCompany Announcements
RenovoRx Appoints Veteran Executive Mark Voll as CFO
5M ago
8K
RNXT
RenovoRx appoints Voll as Chief Financial Officer
PremiumThe FlyRenovoRx appoints Voll as Chief Financial Officer
6M ago
RNXT
RenovoRx announces new clinical data on TAMP therapy platform
Premium
The Fly
RenovoRx announces new clinical data on TAMP therapy platform
6M ago
RNXT
RenovoRx initiated with a Buy at JonesResearch
Premium
The Fly
RenovoRx initiated with a Buy at JonesResearch
6M ago
RNXT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >